GIS Guest Expert Henry I. Miller, MS, MD, is the Robert Wesson Fellow in Scientific Philosophy and Public Policy at Stanford University's Hoover Institution. His research focuses on public policy toward science and technology, encompassing several areas, including pharmaceutical development, genetic engineering, models for regulatory reform, and the emergence of new viral diseases.
Dr. Miller served for 15 years at the U.S. Food and Drug Administration (FDA) in a number of posts. He was the medical reviewer for the first genetically engineered drugs to be evaluated by the FDA and thus instrumental in the rapid licensing of human insulin and human growth hormone. As a government official, Dr. Miller received numerous awards and citations.
Since coming to the Hoover Institution, Dr. Miller's work has been widely published in many languages. Monographs include Policy Controversy in Biotechnology: An Insider's View; To America's Health: A Model for Reform of the Food and Drug Administration; and The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution. Barron's selected The Frankenfood Myth as one of the 25 Best Books of 2004. In addition, Dr. Miller has published extensively in a wide spectrum of scholarly journals and prestigious publications worldwide. He appears regularly on two nationally syndicated radio programs.